Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)

PHASE3RecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

August 13, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2027

Conditions
Acute Respiratory Distress Syndrome (ARDS)
Interventions
DRUG

Metoprolol Injection

"A dilution of 15 mg Metoprolol tartrate in 100 ml saline shall be performed and infused for 10 minutes. No dose reduction or increase is allowed. Systolic blood pressure and heart rate shall be measured 3 and 6 minutes after starting the infusion.~In case of a consistent drop in systolic blood pressure or heart rate, the infusion shall be stopped and the infusion noted."

DRUG

saline 0.9%

"A dilution of 0.9% sodium chloride in 100 ml saline shall be performed and infused for 10 minutes. No dose reduction or increase is allowed. Systolic blood pressure and heart rate shall be measured 3 and 6 minutes after starting the infusion.~In case of a consistent drop in systolic blood pressure below 110 mmHg or heart rate below 60 bpm, the infusion shall be stopped and the infusion noted."

Trial Locations (10)

Unknown

ACTIVE_NOT_RECRUITING

Hospital Universitario de Jerez de La Frontera, Jerez de la Frontera

NOT_YET_RECRUITING

Hospital Universitario de Toledo, Toledo

ACTIVE_NOT_RECRUITING

Hospital Clinic, Barcelona

NOT_YET_RECRUITING

Hospital Parc Taulí, Barcelona

RECRUITING

Fundación Jiménez Díaz University Hospital, Madrid

ACTIVE_NOT_RECRUITING

Hospital Clínico San Carlos, Madrid

NOT_YET_RECRUITING

Hospital de Getafe, Madrid

ACTIVE_NOT_RECRUITING

Hospital General de Villalba, Madrid

ACTIVE_NOT_RECRUITING

Hospital La Paz, Madrid

RECRUITING

Hospital Rey Juan Carlos, Madrid

All Listed Sponsors
collaborator

European Commission

OTHER

collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Consorcio Centro de Investigación Biomédica en Red (CIBER)

OTHER_GOV